Sign up for our bi-monthly email to get the latest news on treatments, support, and stories from the brain tumor community.
**Sponsored Content** Advancements in brain tumor treatments are made possible by patients who volunteer to participate in clinical trials.
We need 500 people to donate or share their story for the ABTA’s first Day of Giving during Brain Tumor Awareness Month. Are you in?
David Hou is awarded for his research on leveraging a B cell vaccine to improve immunotherapy treatment for GBM.
**Sponsored Content**
For adult patients with recurrent GBM, a new clinical trial may offer access to emerging solutions and novel therapies unavailable elsewhere.
On November 17, 2022, results from a phase 3 trial of DCVax-L, an immunotherapy for glioblastoma patients, were published in the Journal of the American Medical Association (JAMA) Oncology.
The American Brain Tumor Association (ABTA) today announced a new partnership with Brain Tumour Foundation of Canada (BTFC) to accelerate brain tumor research. Through this partnership, BTFC will invest in the ABTA research program to co-fund a research project in Canada, focused on improving resection for low-grade glioma.
Meet two researchers on opposite ends of the globe dedicated to transforming the future of brain tumor treatments.
A small Virginia community celebrates 25 years of coming together for Justin Porter, a six-year-old who passed away from GBM.
Meet the recipients of the ABTA’s highest honors and learn how they’re making a difference.
Always free for patients & caregivers
Gina & Tim Abbas
Caregiver & Anaplastic Astrocytoma Survivor
Donate now and your gift will be matched thanks to the Will Hicks Charitable Association.
